Hotspot


Archive | 2003

Modified pictet-spengler reaction and products prepared therefrom

Mark W. Orme; Michael John Martinelli; Christopher William Doecke; Joseph Matthew Pawlak; Erik Christopher Chelius


Archive | 2001

Condensed pyridoindole derivatives

Mark W. Orme; Jason Scott Sawyer; Alain Claude-Marie Daugan; Francoise GlaxoSmithKline Gellibert; Romain Luc Marie GlaxoSmithKline Gosmini


Archive | 2001

Derivatives of 2,3,6,7,12,12a-hexahydropyrazino-[1',2':1,6]pyrido[3,4b]-indole-1,4-dione

Mark W. Orme; Jason Scott Sawyer; Alain Claude-Marie Daugan


Archive | 2002

Pyrazino [1'2':1,6 ] pyrido [3, 4-b] indole-1,4-dione derivatives

Mark W. Orme; Jason Scott Sawyer; Lisa M. Schultze


Archive | 2002

Carboline derivatives as inhibitors of phosphodiesterase 5 (PDE5) for the treatment of cardiovascular diseases and erectile dysfunction

Jason Scott Sawyer; Mark W. Orme; James D. Copp


Archive | 2001

Pyrazino[1′,2′:1,6]pyrido[3,4b]indole derivatives

Mark W. Orme; Jason Scott Sawyer; Lisa M. Schultze; Alain Claude-Marie Daugan; Francoise GlaxoSmithKline Gellibert


Archive | 2001

Condensed pyrazindione derivatives

Mark W. Orme; Jason Scott Sawyer; Lisa M. Schultze


Archive | 2002

Tetracyclic compounds as pde5-inhibitors

Mark W. Orme; Jason Scott Sawyer; Lisa M. Schultze


Archive | 2001

Hexahydropyrazino[1'2';1,6]pyrido[3,4-b]indole-1,4-diones for the treatment of cardiovascular disorders and erectile dysfunction

Mark W. Orme; Lisa M. Schultze; Jason Scott Sawyer; Alain Claude-Marie Daugan; Raymond F. Brown


Archive | 2009

MODIFIED PICTET-SPENGLER REACTION AND PRODUCT PRODUCED THEREFROM

Erik Christopher Chelius; Christopher William Doecke; Michael John Martinelli; Mark W. Orme; Joseph Matthew Pawlak; マーク ダブリュ. オーム,; エリック クリストファー チェリウス; クリストファー ウィリアム ドーク; ジョセフ マシュー ポウラック; マイケル・ジョン・マーティネリ

Researchain Logo
Decentralizing Knowledge